Fondaparinux Sodium Injection
Product Images NDC 0781-3443

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 25 technical images submitted to the FDA as part of the official labeling for Fondaparinux Sodium (NDC 0781-3443). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Sandoz Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

Product Images & Figures Index

FDA Label Image

10 mg 10-pack Carton Label (10mg 10pack)

10 mg 10-pack Carton Label (10mg 10pack)
Fondaparinux Sodium Injection, USP 10 mg per 0.8 mL subcutaneous injection, in a carton labeled for 10 single-dose prefilled syringes. The label includes manufacturer information, storage instructions, and barcode. The product is from Sandoz Inc., with manufacturing by Jiangsu Hengrui Pharmaceuticals Co., Ltd., China.*
FDA Label Image

10 mg 2-pack Carton Label (10mg 2pack)

10 mg 2-pack Carton Label (10mg 2pack)
Fondaparinux Sodium Injection, USP 10 mg per 0.8 mL single-dose prefilled syringes. The label states the product is for subcutaneous injection, includes 2 syringes per package, and is labeled for prescription use only. Manufactured by Jiangsu Hengrui Pharmaceuticals for Sandoz Inc., this package includes an automatic needle protection system and instructions to dispense a patient information leaflet.*
FDA Label Image

2.5 mg 10-pack Carton Label (2 5mg 10pack)

2.5 mg 10-pack Carton Label (2 5mg 10pack)
Carton packaging for Fondaparinux Sodium Injection, USP 2.5 mg per 0.5 mL, a subcutaneous injection by Sandoz Inc. The label indicates 10 single-dose prefilled syringes with an automatic needle protection system. The box includes storage instructions, manufacturer details (Jiangsu Hengrui Pharmaceuticals Co., Ltd., China), and usage information stating Rx only and pharmacist dispensing instructions.*
FDA Label Image

2.5 mg 2-pack Carton Label (2 5mg 2pack)

2.5 mg 2-pack Carton Label (2 5mg 2pack)
Fondaparinux Sodium Injection, USP 2.5 mg per 0.5 mL single-dose prefilled syringes packaging label. The label states it is for subcutaneous injection, Rx only, and contains two prefilled syringes with an automatic needle protection system. Manufactured by Jiangsu Hengrui Pharmaceuticals Co., Ltd. for Sandoz Inc. The label includes storage instructions and a barcode.*
FDA Label Image

5 mg 10-pack Carton Label (5mg 10pack)

5 mg 10-pack Carton Label (5mg 10pack)
Packaging label for Fondaparinux Sodium Injection, USP 5 mg per 0.4 mL, produced by Sandoz Inc. The label states it is for subcutaneous injection and contains 10 single-dose prefilled syringes with automatic needle protection. Manufactured in China by Jiangsu Hengrui Pharmaceuticals Co., Ltd., the label includes storage instructions and the NDC 0781-3454-95.*
FDA Label Image

5 mg 2-pack Carton Label (5mg 2pack)

5 mg 2-pack Carton Label (5mg 2pack)
Box packaging label for Fondaparinux Sodium Injection USP, 5 mg per 0.4 mL, a subcutaneous injection by Sandoz Inc. The label states it contains 2 single-dose prefilled syringes with an automatic needle protection system. Manufactured in China by Jiangsu Hengrui Pharmaceuticals Co., Ltd., the label includes storage instructions and directions to dispense a patient information leaflet.*
FDA Label Image

7.5 mg 10-pack Carton Label (7 5mg 10pack)

7.5 mg 10-pack Carton Label (7 5mg 10pack)
Packaging label for Fondaparinux Sodium Injection, USP 7.5 mg per 0.6 mL, a subcutaneous injection supplied as 10 single-dose prefilled syringes. The label includes dosing instructions, storage conditions, manufacturer information (Jiangsu Hengrui Pharmaceuticals for Sandoz Inc.), and a barcode. The product is Rx only and includes an automatic needle protection system.*
FDA Label Image

7.5 mg 2-pack Carton Label (7 5mg 2pack)

7.5 mg 2-pack Carton Label (7 5mg 2pack)
Packaging label for Fondaparinux Sodium Injection, USP 7.5 mg per 0.6 mL, a subcutaneous injection presented in two single-dose prefilled syringes. Manufactured for Sandoz Inc. and produced by Jiangsu Hengrui Pharmaceuticals in China. The label includes storage instructions, dosage recommendation, and notes on automatic needle protection and patient information leaflet dispensing.*
FDA Label Image

Figure 1 (Figure 1)

Figure 1 (Figure 1)
Instructional image showing hands wearing gloves preparing a Fondaparinux Sodium subcutaneous injection. The image highlights holding a prefilled syringe with a visible dosage marking and a needle cap, demonstrating the correct orientation and handling technique for administration.*
FDA Label Image

Figure 2 (Figure 2)

Figure 2 (Figure 2)
An instructional illustration showing the administration of a subcutaneous injection. The image depicts a syringe delivering an injection into the upper arm or shoulder area, demonstrating proper injection technique.*
FDA Label Image

Figure 3 (Figure 3)

Figure 3 (Figure 3)
An instructional photograph showing a close-up of a person receiving a subcutaneous injection in the abdomen area using a prefilled syringe. The syringe is clear and appears to be ready for administration. White-gloved hands hold the syringe, demonstrating correct technique for subcutaneous injection.*
FDA Label Image

Figure 4 (Figure 4)

Figure 4 (Figure 4)
An instructional photograph showing a healthcare professional administering a subcutaneous injection into a patient's arm. The patient is seated while the injector, wearing gloves, holds a syringe with needle inserted into the skin. The image highlights the injection technique.*
FDA Label Image

Figure 5 (Figure 5)

Figure 5 (Figure 5)
Fondaparinux Sodium injection vial held in a gloved hand. The vial is small and clear with a label showing the product name. The image highlights the vial's size and presentation for subcutaneous injection. Labeler name Sandoz Inc. is referenced in product data but not visible in the image.*
FDA Label Image

Figure 6 (Figure 6)

Figure 6 (Figure 6)
An instructional photo showing a hand holding a prefilled syringe of Fondaparinux Sodium injection. An arrow indicates the direction to remove a protective cover or cap from the syringe needle before administration. The image demonstrates preparation steps for subcutaneous injection.*
FDA Label Image

Figure A (Figure A)

Figure A (Figure A)
A black-and-white photo showing a person with their shirt lifted to expose the abdomen. One hand is positioned just above the belt line, and the image suggests preparation for subcutaneous injection in the abdominal area. This illustration relates to administering Fondaparinux Sodium injection subcutaneously.*
FDA Label Image

Figure B (Figure B)

Figure B (Figure B)
An instructional illustration showing two hands holding a prefilled syringe of Fondaparinux Sodium injection. An arrow indicates a step in the preparation or administration process, likely related to removing the needle cap or preparing for subcutaneous injection.*
FDA Label Image

Figure C (Figure C)

Figure C (Figure C)
A black and white photograph showing a person's abdominal area with two hands demonstrating pinching the skin to lift it. Two arrows point towards the pinched skin area, indicating the site for a subcutaneous injection. This image illustrates proper technique for administering a subcutaneous injection, relevant for Fondaparinux Sodium injection use.*
FDA Label Image

Figure D (Figure D)

Figure D (Figure D)
Black and white photograph showing a healthcare professional administering a subcutaneous injection into the forearm of a patient. The image depicts a close-up of the injection technique with the syringe in place, illustrating the proper method of delivering a subcutaneous injection.*
FDA Label Image

Figure E (Figure E)

Figure E (Figure E)
Illustration showing a person self-administering a subcutaneous injection using a prefilled syringe, relevant to Fondaparinux Sodium injection for subcutaneous use.*
FDA Label Image

Figure F (Figure F)

Figure F (Figure F)
An illustration showing a person administering a subcutaneous injection with a syringe into the abdomen. The image depicts the proper technique for injecting Fondaparinux Sodium, highlighting the subcutaneous route of administration.*
FDA Label Image

Figure G (Figure G)

Figure G (Figure G)
FDA Label Image

Structural Formula (Structural Formula)

Structural Formula (Structural Formula)
Chemical structure of Fondaparinux Sodium, showing its complex polysaccharide chain with multiple sulfate and carboxylate groups.*
FDA Label Image

Syringe After Use (Syringe After Use)

Syringe After Use (Syringe After Use)
Image of a Fondaparinux Sodium injection syringe, showing the pre-filled syringe body with measurement markings, plunger, and needle cover. The syringe is intended for subcutaneous injection and is one of several available strengths manufactured by Sandoz Inc.*
FDA Label Image

Syringe Before Use (Syringe Before Use)

Syringe Before Use (Syringe Before Use)
Fondaparinux Sodium injection prefilled syringe in a clear plastic body with visible internal components, including a black plunger and measurement markings. The syringe is designed for subcutaneous administration and features a graduated barrel indicating dosage volumes. No specific strength or volume labeling is visible in the image. The product is labeled by Sandoz Inc.*
FDA Label Image

Syringe (Syringe)

Syringe (Syringe)
Fondaparinux Sodium injection prefilled syringe from Sandoz Inc. The syringe contains a clear solution for subcutaneous administration. Visible components include the plunger, barrel with measurement markings, needle hub, and needle cover. No specific strength or dosage volume is visible on this syringe image.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.